|
CAND1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.91199999999281E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.044700E-04 |
| Normal-vs-Stage2 |
3.042800E-03 |
| Normal-vs-Stage3 |
3.39449999997576E-06 |
| Normal-vs-Stage4 |
4.02740000000623E-05 |
| Stage1-vs-Stage2 |
4.377400E-01 |
| Stage1-vs-Stage3 |
4.411600E-02 |
| Stage1-vs-Stage4 |
7.454100E-02 |
| Stage2-vs-Stage3 |
5.372800E-01 |
| Stage2-vs-Stage4 |
5.608000E-01 |
| Stage3-vs-Stage4 |
9.988800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.55257999999714E-05 |
| Normal-vs-AfricanAmerican |
7.32119999957703E-07 |
| Normal-vs-Asian |
1.914010E-01 |
| Caucasian-vs-AfricanAmerican |
7.431600E-02 |
| Caucasian-vs-Asian |
7.998000E-01 |
| AfricanAmerican-vs-Asian |
2.878400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.68039999984771E-07 |
| Normal-vs-Female |
1.198400E-03 |
| Male-vs-Female |
1.426770E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.732280E-02 |
| Normal-vs-Age(41-60Yrs) |
2.179700E-04 |
| Normal-vs-Age(61-80Yrs) |
1.90293999999813E-05 |
| Normal-vs-Age(81-100Yrs) |
3.79900000000433E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.955000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.700000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.685200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.149600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.112400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.188810E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.751950E-01 |
| Normal-vs-Grade 2 |
1.997660E-03 |
| Normal-vs-Grade 3 |
1.20650000001721E-06 |
| Normal-vs-Grade 4 |
1.83350000004801E-06 |
| Grade 1-vs-Grade 2 |
8.558000E-01 |
| Grade 1-vs-Grade 3 |
2.743000E-01 |
| Grade 1-vs-Grade 4 |
1.540020E-01 |
| Grade 2-vs-Grade 3 |
1.665560E-02 |
| Grade 2-vs-Grade 4 |
7.095200E-03 |
| Grade 3-vs-Grade 4 |
2.637200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.241500E-03 |
| Normal-vs-ccB subtype |
3.65370000000587E-05 |
| ccA subtype-vs-ccB subtype |
6.918100E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.189110E-04 |
| Normal-vs-N1 |
3.957200E-01 |
| N0-vs-N1 |
6.955800E-01 |
|
|
